相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo
Sandra Gunesch et al.
REDOX BIOLOGY (2020)
Roflupram exerts neuroprotection via activation of CREB/PGC-1 alpha signalling in experimental models of Parkinson's disease
Jiahong Zhong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
SIRT1 and aging related signaling pathways
Cui Chen et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2020)
Ferulic Acid Rescues LPS-Induced Neurotoxicity via Modulation of the TLR4 Receptor in the Mouse Hippocampus
Shafiq Ur Rehman et al.
MOLECULAR NEUROBIOLOGY (2019)
Phosphodiesterases as therapeutic targets for respiratory diseases
Haoxiao Zuo et al.
PHARMACOLOGY & THERAPEUTICS (2019)
FCPR16, a novel phosphodiesterase 4 inhibitor, produces an antidepressant-like effect in mice exposed to chronic unpredictable mild stress
Qiuping Zhong et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK313/ β-catenin signaling pathway
Bingtian Xu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP+-induced oxidative insult
Jiahong Zhong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
SIRT1 activation by butein attenuates sepsis-induced brain injury in mice subjected to cecal ligation and puncture via alleviating inflammatory and oxidative stress
Yanrong Zhu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Heme oxygenase-1 induction by rosiglitazone via PKC alpha/AMPK alpha/p38 MAPK alpha/SIRT1/PPAR gamma pathway suppresses lipopolysaccharide-mediated pulmonary inflammation
Rou-Ling Cho et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Identification of a PDE4-Specific Pocket for the Design of Selective Inhibitors
Xiaoqing Feng et al.
BIOCHEMISTRY (2018)
Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway
Qun Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The phosphodiesterase-4 inhibitor, FCPR16, attenuates ischemia-reperfusion injury in rats subjected to middle cerebral artery occlusion and reperfusion
Jiajia Chen et al.
BRAIN RESEARCH BULLETIN (2018)
Inflammatory and cytotoxic effects of bifenthrin in primary microglia and organotypic hippocampal slice cultures
Brahim Gargouri et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Screening of quorum sensing peptides for biological effects in neuronal cells
Yorick Janssens et al.
PEPTIDES (2018)
Inhibitory Effects of Betulinic Acid on LPS-Induced Neuroinflammation Involve M2 Microglial Polarization via CaMKK beta-Dependent AMPK Activation
Chuwen Li et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Lipopolysaccharide-Induced Dephosphorylation of AMPK-Activated Protein Kinase Potentiates Inflammatory Injury via Repression of ULK1-Dependent Autophagy
Kerui Fan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cathelicidin-WA attenuates LPS-induced inflammation and redox imbalance through activation of AMPK signaling
Weiche Wu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
The identity and function of microglia in neurodegeneration
Wilbur M. Song et al.
NATURE IMMUNOLOGY (2018)
AMPK: Potential Therapeutic Target for Ischemic Stroke
Shuai Jiang et al.
THERANOSTICS (2018)
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Heng Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury
Haihong Chen et al.
JOURNAL OF NEUROSCIENCE (2017)
Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-κB Inhibition
Zheng-Qiang Zou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice
Hongfang Feng et al.
LABORATORY INVESTIGATION (2017)
AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia
Ravikanth Velagapudi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and antiinflammatory effects
Haibiao Guo et al.
NEUROPHARMACOLOGY (2017)
Roflupram, a Phosphodiesterase 4 Inhibitior, Suppresses Inflammasome Activation through Autophagy in Microglial Cells
Tingting You et al.
ACS CHEMICAL NEUROSCIENCE (2017)
The fate of the brain cholinergic neurons in neurodegenerative diseases
Giancarlo Pepeu et al.
BRAIN RESEARCH (2017)
Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice
Raphaela Mayerhofer et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions
Naisargee Parikh et al.
CURRENT MEDICINAL CHEMISTRY (2016)
PDE4B as a Microglia Target to Reduce Neuroinflammation
Damien D. Pearse et al.
GLIA (2016)
Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor
David J. Titus et al.
JOURNAL OF NEUROSCIENCE (2016)
Phosphodiesterase-4 inhibition as a therapeutic strategy for metabolic disorders
C. Wu et al.
OBESITY REVIEWS (2016)
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation
Anja Henn
ALTEX-Alternatives to Animal Experimentation (2016)
Inhibition of adenosine monophosphate-activated protein kinase reduces glial cell-mediated inflammation and induces the expression of Cx43 in astroglias after cerebral ischemia
Yu Ma et al.
BRAIN RESEARCH (2015)
Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
John C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
RNA Interference-Mediated Knockdown of Long-Form Phosphodiesterase-4D (PDE4D) Enzyme Reverses Amyloid-β42-Induced Memory Deficits in Mice
Cong Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Inhibition of AMP-Activated Protein Kinase Accentuates Lipopolysaccharide-Induced Lung Endothelial Barrier Dysfunction and Lung Injury in Vivo
Junjie Xing et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
AMP-activated protein kinase: A target for old drugs against diabetes and cancer
Gian Luigi Russo et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis
C. Gonzalez-Garcia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Chronological changes and effects of AMP-activated kinase in the hippocampal CA1 region after transient forebrain ischemia in gerbils
Han Ga Wi Nam et al.
NEUROLOGICAL RESEARCH (2013)
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung-Jun Park et al.
CELL (2012)
Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury
Mousumi Ghosh et al.
GLIA (2012)
AMPK and SIRT1: a long-standing partnership?
Neil B. Ruderman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Design, Synthesis, and Structure-Activity Relationship, Molecular Modeling, and NMR Studies of a Series of Phenyl Alkyl Ketones as Highly Potent and Selective Phosphodiesterase-4 Inhibitors
Shilong Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures
Ryan J. Horvath et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
SLC Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
